WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology (stock code 603718.SH). The business model of WuXi Vaccines is
The post WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract appeared first on Pharmaceutical Business review.